These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16514404)

  • 21. Infliximab as first-line therapy for Crohn's disease is premature.
    Greenberg GR
    Inflamm Bowel Dis; 2002 Jan; 8(1):60-2; discussion 63-5. PubMed ID: 11837941
    [No Abstract]   [Full Text] [Related]  

  • 22. Infliximab in Crohn's disease.
    Rodrigo Saéz L
    Rev Esp Enferm Dig; 2004 Jun; 96(6):359-63; 364-8. PubMed ID: 15230665
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of oesophageal Crohn's disease with infliximab.
    Theodoropoulou A; Koutroubakis IE; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):431-2. PubMed ID: 15028980
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful infliximab therapy for oral Crohn's disease.
    Cardoso H; Nunes AC; Carneiro F; Tavarela Veloso F
    Inflamm Bowel Dis; 2006 Apr; 12(4):337-8. PubMed ID: 16633058
    [No Abstract]   [Full Text] [Related]  

  • 25. Infliximab and Crohn's QOL.
    Wicks AC; Thomas C; Curran R; Mayberry JF
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1831-2. PubMed ID: 12269979
    [No Abstract]   [Full Text] [Related]  

  • 26. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 27. Infliximab: how to use it in pediatric Crohn's disease.
    Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):12-4. PubMed ID: 15187774
    [No Abstract]   [Full Text] [Related]  

  • 28. Infliximab for Crohn's disease: more questions than answers.
    Freeman HJ
    Can J Gastroenterol; 2001 Jun; 15(6):360-2. PubMed ID: 11429663
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
    Domènech E; Esteve-Comas M; Gomollón F; Hinojosa J; Obrador A; Panés J; Gassull MA;
    Gastroenterol Hepatol; 2002 Mar; 25(3):162-9. PubMed ID: 11864540
    [No Abstract]   [Full Text] [Related]  

  • 30. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
    Osuna Molina R; Ferrer Ríos T; Gallego Gallegos R; Ramos Lora M; Ynfante Ferrús M; Figueruela López B
    Rev Esp Enferm Dig; 2006 Jan; 98(1):60-1. PubMed ID: 16555939
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful use of infliximab for perianal Crohn's disease in pregnancy.
    Chaparro M; Gisbert JP
    Inflamm Bowel Dis; 2011 Mar; 17(3):868-9. PubMed ID: 20564533
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-term efficacy and predictors of response to infliximab in Korean patients with Crohn's disease].
    Lee KM
    Korean J Gastroenterol; 2013 May; 61(5):241-5. PubMed ID: 23905245
    [No Abstract]   [Full Text] [Related]  

  • 33. The prevalence of malnutrition and the evolution of nutritional status in patients with moderate to severe forms of Crohn's disease treated with Infliximab.
    Vadan R; Gheorghe LS; Constantinescu A; Gheorghe C
    Clin Nutr; 2011 Feb; 30(1):86-91. PubMed ID: 20719413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab is the drug we have been waiting for in Crohn's disease.
    Rutgeerts P
    Inflamm Bowel Dis; 2000 May; 6(2):132-6. PubMed ID: 10833073
    [No Abstract]   [Full Text] [Related]  

  • 35. The real cost of pediatric Crohn's disease: the role of infliximab in the treatment of pediatric IBD.
    Kay M; Wyllie R
    Am J Gastroenterol; 2003 Apr; 98(4):717-20. PubMed ID: 12738445
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S36-9. PubMed ID: 11685974
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment-resistant lingual Crohn's disease disappears after infliximab.
    Brunner B; Hirschi C; Weimann R; Seibold F
    Scand J Gastroenterol; 2005 Oct; 40(10):1255-9. PubMed ID: 16265783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab (Remicade): the magic bullet for Crohn's disease?
    D'Haens G
    Dig Liver Dis; 2000 Nov; 32(8):653-6. PubMed ID: 11142571
    [No Abstract]   [Full Text] [Related]  

  • 39. Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
    Panaccione R; Fedorak RN; Aumais G; Bernstein CN; Bitton A; Croitoru K; Enns R; Feagan B; Fishman M; Greenberg G; Griffiths A; Marshall JK; Rasul I; Sadowski D; Seidman E; Steinhart H; Sutherland L; Walli E; Wild G; Williams CN; Zachos M;
    Can J Gastroenterol; 2004 Aug; 18(8):503-8. PubMed ID: 15372114
    [No Abstract]   [Full Text] [Related]  

  • 40. Discussion on predictors of response to infliximab in patients with Crohn's disease.
    Hommes D
    Gastroenterology; 2003 Jun; 124(7):2002-3. PubMed ID: 12812196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.